Gunn et al. Serra, M., Pisu, M. G., Mostallino, M. C., Sanna, E., and Biggio, G. (2008). Changes in neuroactive steroid con- tent during social isolation stress modulate GABAA receptor plastic- ity and function. Brain Res. Rev. 57, 520–530. Serra, M., Pisu, M. G., Muggironi, M., Parodo, V., Papi, G., Sari, R., Dazzi, L., Spiga, F., Purdy, R. H., and Big- gio, G. (2001). Opposite effects of short- versus long-term administra- tion of ﬂuoxetine on the concentra- tions of neuroactive steroids in rat plasma and brain. Psychopharmacol- ogy (Berl.) 158, 48–54. Shen, H., Sabaliauskas, N., Sherpa, A., Fenton, A. A., Stelzer, A., Aoki, C., and Smith, S. S. (2010). A critical role for α4βδ GABAA receptors in shap- ing learning defeci8ts at puberty in mice. Science 327, 1515–1518. Sierra, A. (2004). Neurosteroids: the StAR protein in the brain. J. Neu- roendocrinol. 16, 787–793. Singh, C., Liu, L., Wang, J. M., Irwin, R. W., Yao, J., Chen, S., Henry, S., Thompson, R. F., and Brinton, R. D. (2011). Allopregnanolone restores hippocampal-dependent learning and memory and neural progenitor survival in aging 3xTgAD and nonTg mice. Neurobiol. Aging. doi: 10.1016/j.neurobiolaging.2011.06. 008 Smith, S. S., Ruderman, Y., Frye, C., Homanics, G., and Yuan, M. (2006). Steroid withdrawal in the mouse results in anxiogenic effects of 3α, 5β-THP: a possible model of premenstrual dysphoric disor- der. Psychopharmacology (Berl.) 186, 323–333. Sotiropoulos, I., Catania, C., Pinto, L. G., Silva, R., Pollerberg, G. E., Takashima, A., Sousa, N., and Almeida, O. F. (2011). Stress acts cumulatively to precipi- tate Alzheimer’s disease-like tau pathology and cognitive deﬁcits. J. Neurosci. 31, 7840–7847. Sundstrom-Poromaa, I. (2004). “Pre- menstrual dysphoric disorder,” in Neurosteroid Effects in the Central Nervous System, ed. S. S. Smith (Boca Raton: CRC Press), 291–304. Swanson, L. W., Sawchenko, P. E., Rivier, J., and Vale, W. W. (1983). Orga- nization of ovine corticotropin- releasing factor immunoreactive cells and ﬁbers in the rat brain: an immunohistochemical study. Neu- roendocrinology 36, 165–186. Swanson, L. W., and Simmons, D. M. (1989). Differential steroid hormone and neural inﬂuences on peptide mRNA levels in CRH cells of the www.frontiersin.org paraventricular nucleus: a hybridiza- tion histochemical study in the rat. J. Comp. Neurol. 285, 413–435. Szabadics, J.,Varga, C., Molnar, G., Olah, S., Barzo, P., and Tamas, G. (2006). Excitatory effect of GABAergic axo- axonic cells in cortical microcircuits. Science 311, 233–235. Tasker, J. G., and Herman, J. P. (2011). Mechanisms of rapid glu- cocorticoid feedback inhibition of the hypothalamic-pituitary-adrenal axis. Stress 14, 398–406. Tokuda, K., Izumi, Y., and Zorum- ski, C. F. (2011). Ethanol enhances neurosteroidogenesis in hippocam- pal pyramidal neurons by paradox- ical NMDA receptor activation. J. Neurosci. 31, 9905–9909. Tokuda, K., O’Dell, K. A., Izumi, Y., and Zorumski, C. F. (2010). Midazo- lam inhibits hippocampal long-term potentiation and learning through dual central and peripheral benzodi- azepine receptor activation and neu- rosteroidogenesis. J. Neurosci. 30, 16788–16795. Torres, J. M., Ruiz, E., and Ortega, E. (2001). Effects of CRH and ACTH administration on plasma and brain neurosteroid levels. Neurochem. Res. 26, 555–558. Trauger, J. W., Jiang, A., Stearns, B. A., and LoGrasso, P. V. (2002). Kinetics of allopregnanolone formation cat- alyzed by human 3α-hydroxysteroid dehydrogenase type III (AKR1C2). Biochemistry 41, 13451–13459. Trigo, F. F., Marty, A., and Stell, B. M. (2008). Axonal GABAA receptors. Eur. J. Neurosci. 28, 841–848. Tsankova, N., Renthal, W., Kumar, A., and Nestler, E. J. (2007). Epigenetic regulation in psychiatric disorders. Nat. Rev. Neurosci. 8, 355–367. Tsutsui, K. (2008). Neurosteroids in the Purkinje cell: biosynthesis, mode of action and functional signiﬁcance. Mol. Neurobiol. 37, 116–125. Uchida, S., Noda, E., Kakazu, Y., Mizoguchi, Y., Akaike, N., and Nabekura, J. (2002). Allo- pregnanolone enhancement of GABAergic transmission in rat medial preoptic area neurons. Am. J. Physiol. Endocrinol. Metab. 283, E1257–E1265. Ulrich-Lai, Y. M., and Herman, J. P. (2009). Neural regulation of endocrine and autonomic stress responses. Nat. Rev. Neurosci. 10, 397–409. Uzunov, D. P., Cooper, T. B., Costa, E., and Guidotti, A. (1996). Fluoxetine-elicited changes in brain neurosteroid content measured by negative ion mass fragmentography. Proc. Natl. Acad. Sci. U.S.A. 93, 12599–12604. Uzunova, V., Sampson, L., and Uzunov, D. P. (2006). Relevance of endoge- nous 3alpha-reduced neurosteroids to depression and antidepressant action. Psychopharmacology (Berl.) 186, 351–361. Uzunova, V., Sheline, Y., Davis, J. M., Rasmusson, A., Uzunov, D. P., Costa, E., and Guidotti, A. (1998). Increase in the cerebrospinal ﬂuid content of neurosteroids in patients with unipolar major depression who are receiving ﬂuoxetine or ﬂuvoxam- ine. Proc. Natl. Acad. Sci. U.S.A. 95, 3239–3244. Vale, W., Spiess, J., Rivier, C., and Riv- ier, J. (1981). Characterization of a 41-residue ovine hypothalamic pep- tide that stimulates secretion of cor- ticotropin and beta-endorphin. Sci- ence 213, 1394–1397. VanDoren, M. J., Matthews, D. B., Janis, G. C., Grobin, A. C., Devaud, L. L., and Morrow, A. L. (2000). Neuroactive steroid 3α-hydroxy- 5α-pregnan-20-one modulates electrophysiological and behavioral actions of ethanol. J. Neurosci. 20, 1982–1989. Verkuyl, J. M., Hemby, S. E., and Joels, M. (2004). Chronic stress attenu- ates GABAergic inhibition and alters gene expression of parvocellular neurons in rat hypothalamus. Eur. J. Neurosci. 20, 1665–1673. Verleye, M., Akwa, Y., Liere, P., Ladurelle, N., Pianos, A., Eychenne, B., Schu- macher, M., and Gillardin, J. M. (2005). The anxiolytic etifoxine activates the peripheral benzodi- azepine receptor and increases the neurosteroid levels in rat brain. Pharmacol. Biochem. Behav. 82, 712–720. Wang, J. M., Johnston, P. B., Ball, B. G., and Brinton, R. D. (2005). The neurosteroid allopregnanolone promotes proliferation of rodent and human neural progenitor cells and regulates cell-cycle gene and protein expression. J. Neurosci. 25, 4706–4718. Wang, J. M., Liu, L., Irwin, R. W., Chen, S., and Brinton, R. D. (2008). Regenerative potential of allopregnanolone. Brain Res. Rev. 57, 398–409. Wang, J. M., Singh, C., Liu, L., Irwin, R. W., Chen, S., Chung, E. J., Thomp- son, R. F., and Brinton, R. D. (2010). Allopregnanolone reverses neurogenic and cognitive deﬁcits in mouse model of Alzheimer’s dis- ease. Proc. Natl. Acad. Sci. U.S.A. 107, 6498–6503. GABAA receptors, neurosteroids, and stress Weaver, I. C., Cervoni, N., Champagne, F. A., D’Alessio, A. C., Sharma, S., Seckl, J. R., Dymov, S., Szyf, M., and Meaney, M. J. (2004). Epigenetic programming by maternal behavior. Nat. Neurosci. 7, 847–854. Wei, W., Zhang, N., Peng, Z., Houser, C. R., and Mody, I. (2003). Perisy- naptic localization of delta subunit- containing GABAA receptors and their activation by GABA spillover in the mouse dentate gyrus. J. Neurosci. 23, 10650–10661. Weill-Engerer, S., David, J. P., Saz- dovitch, V., Liere, P., Eychenne, B., Pianos, A., Schumacher, M., Dela- courte, A., Baulieu, E. E., and Akwa, Y. (2002). Neurosteroid quantiﬁ- cation in human brain regions: comparison between Alzheimer’s and nondemented patients. J. Clin. Endocrinol. Metab. 87, 5138–5143. Welberg, L. A., and Seckl, J. R. (2001). Prenatal stress, glucocorticoids and the programming of the brain. J. Neuroendocrinol. 13, 113–128. Wisden, W., Laurie, D. J., Monyer, H., and Seeburg, P. H. (1992). The distribution of 13 GABAA receptor subunit mRNAs in the rat brain. I. Telencephalon, dien- cephalon, mesencephalon. J. Neu- rosci. 12, 1040–1062. Womack, M. D., Pyner, S., and Barrett-Jolley, R. (2006). Inhibition by α-tetrahydrodeoxycorticosterone (THDOC) of pre-sympathetic par- vocellular neurones in the paraven- tricular nucleus of rat hypothala- mus. Br. J. Pharmacol. 149, 600–607. Woolley, C. S., Gould, E., and McEwen, B. S. (1990). Exposure to excess glu- cocorticoids alters dendritic mor- phology of adult hippocampal pyra- midal neurons. Brain Res. 531, 225–231. Zimmerberg, B., and Blaskey, L. G. (1998). Prenatal stress effects are partially ameliorated by prena- tal administration of the neuros- teroid allopregnanolone. Pharmacol. Biochem. Behav. 59, 819–827. Zimmerberg, B., Brunelli, S. A., and Hofer, M. A. (1994). Reduction of rat pup ultrasonic vocalizations by the neuroactive steroid allo- pregnanolone. Pharmacol. Biochem. Behav. 47, 735–738. Zimmerberg, B., and Kajunski, E. W. (2004). Sexually dimorphic effects of postnatal allopregnanolone on the development of anxiety behavior after early deprivation. Pharmacol. Biochem. Behav. 78, 465–471. Zimmerberg, B., Rackow, S. H., and George-Friedman, K. P. (1999). Sex- dependent behavioral effects of the December 2011 | Volume 5 | Article 131 | 19